Neuralstem Inc (CUR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Neuralstem Inc (CUR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011472
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuralstem Inc (Neuralstem) is a developer of medicines for nervous system diseases. The company offers cell therapy treatment for ALS, ischemic stroke, spinal cord injury, multiple sclerosis, optic neuritis, Alzheimer’s disease, traumatic brain injury, peripheral nerve injury, diabetic neuropathy, lysosomal disease, Parkinson’s disease, huntington’s disease and cerebral palsy, among others. It provides drug treatment for depressive disorder, cognitive complication due to diabetes, post traumatic stress disorder, neurodegeneration and anti aging. The company develops methods to generate replacement cells from neural stem cells. Neuralstem is headquartered in Germantown, Maryland, the US.

Neuralstem Inc (CUR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neuralstem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Neuralstem Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Neuralstem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Neuralstem Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Neuralstem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Neuralstem Inc, Medical Equipment, Deal Details 10
Partnerships 10
Neuralstem Enters Into Licensing Agreement With Cedars-Sinai Medical Center 10
Neuralstem Enters Into Licensing Agreement With Q Therapeutics For Surgical Device Platform 11
Equity Offering 12
Neuralstem Raises USD6 Million Public Offering of Shares and Warrants 12
Neuralstem Raises USD8 Million in Public Offering of Shares 14
Neuralstem Raises USD3.06 Million in Public Offering of Shares 16
Neuralstem Completes Public Offering Of Common Stock For US$2.8 Million 17
Neuralstem Completes Private Placement Of Common Stock For US$5.2 Million 18
Neuralstem Inc – Key Competitors 20
Neuralstem Inc – Key Employees 21
Neuralstem Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Nov 13, 2017: Neuralstem Reports Third Quarter 2017 Fiscal Results and Provides Clinical and Business Update 23
Aug 08, 2017: Neuralstem Reports Second Quarter 2017 Fiscal Results and Provides Clinical and Business Update 25
May 10, 2017: Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update 27
Mar 23, 2017: Neuralstem Reports Year End 2016 Fiscal Results and Business Update 29
Nov 08, 2016: Neuralstem Reports Third Quarter 2016 Results 31
Aug 11, 2016: Neuralstem Reports Second Quarter 2016 Results and Provides Business and Clinical Updates 33
May 09, 2016: Neuralstem Reports Fiscal First Quarter 2016 Results and Business Update 35
Mar 14, 2016: Neuralstem Reports Fourth Quarter and Year End 2015 Fiscal Results and Business Update 37
Corporate Communications 39
Dec 20, 2017: New Member appointed to the Board of Directors of Neuralstem 39
Nov 08, 2017: Neuralstem Strengthens Executive Leadership Team with Appointment of Dr. David Recker as Chief Medical Officer 40
Sep 25, 2017: Neuralstem Announces the Appointment of Two New Members to the Board of Directors 41
Feb 16, 2016: Neuralstem Appoints Richard Daly as President and Chief Executive Officer 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Neuralstem Inc, Medical Equipment, Key Facts, 2016 2
Neuralstem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Neuralstem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Neuralstem Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Neuralstem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Neuralstem Inc, Deals By Market, 2011 to YTD 2017 8
Neuralstem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Neuralstem Enters Into Licensing Agreement With Cedars-Sinai Medical Center 10
Neuralstem Enters Into Licensing Agreement With Q Therapeutics For Surgical Device Platform 11
Neuralstem Raises USD6 Million Public Offering of Shares and Warrants 12
Neuralstem Raises USD8 Million in Public Offering of Shares 14
Neuralstem Raises USD3.06 Million in Public Offering of Shares 16
Neuralstem Completes Public Offering Of Common Stock For US$2.8 Million 17
Neuralstem Completes Private Placement Of Common Stock For US$5.2 Million 18
Neuralstem Inc, Key Competitors 20
Neuralstem Inc, Key Employees 21

★海外企業調査レポート[Neuralstem Inc (CUR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • FMT Aircraft Gate Support Systems AB:企業の戦略・SWOT・財務情報
    FMT Aircraft Gate Support Systems AB - Strategy, SWOT and Corporate Finance Report Summary FMT Aircraft Gate Support Systems AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Hikma Pharmaceuticals Plc (HIK):製薬・医療:M&Aディール及び事業提携情報
    Summary Hikma Pharmaceuticals Plc (Hikma) develops, manufactures and markets branded and non-branded generics and in-licensed products. The company specializes in the therapeutic areas of cardiovascular, diabetes, central nervous system (CNS), cancer, dermatology, genitourinary system, hormones and …
  • Hitachi Ltd (6501):企業の財務・戦略的SWOT分析
    Hitachi Ltd (6501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CaroGen Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary CaroGen Corp (CaroGen) is an immunotherapy company that offers platform technology development services. The company develops and commercializes virus-like vesicle based therapeutic vaccines. It utilizes its virus-like vesicle platform technology for the development of vaccines for infectiou …
  • Ogeda SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ogeda SA (Ogeda), formerly Euroscreen SA, a subsidiary of Astellas Pharma Inc, is a clinical-stage drug discovery company that invents and develops fezolinetant and small molecule drugs targeting G-protein coupled receptors. The company discovers and develops drugs that treat hormone-depende …
  • Cantex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cantex Pharmaceuticals Inc (Cantex), formerly ParinGenix Inc is a clinical stage biopharmaceutical company that focuses on the development of proprietary pharmaceuticals for the treatment of cancers and other disorders. The company's pipeline products include CX-01, a proprietary combination …
  • Haynes International Inc:企業の戦略・SWOT・財務分析
    Haynes International Inc - Strategy, SWOT and Corporate Finance Report Summary Haynes International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Landesbank Hessen Thueringen Girozentrale:企業の戦略・SWOT・財務情報
    Landesbank Hessen Thueringen Girozentrale - Strategy, SWOT and Corporate Finance Report Summary Landesbank Hessen Thueringen Girozentrale - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Warp Drive Bio Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Warp Drive Bio Inc (Warp Drive) is an inventor of therapeutic agents that exploits molecules and createstransformative medicines through nature. The company utilizes its proprietary genomic mining and small molecule assisted receptor targeting platform to develop novel medicines. Its SMART p …
  • Yapi Merkezi Holding Inc.
    Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report Summary Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Carmell Therapeutics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio include adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for total j …
  • Eaton Corporation plc:戦略・SWOT・企業財務分析
    Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report Summary Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • North Central Electric Cooperative, Inc.:企業の戦略的SWOT分析
    North Central Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Canada Energy Partners Inc (CE):企業の財務・戦略的SWOT分析
    Summary Canada Energy Partners Inc (Canada Energy) is a natural gas exploration and development company. The company concentrates on mid-stream supplying of water disposal services, development of a wellbore mining technology and energy or mineral exploring. Canada Energy develops a wellbore mining …
  • Blue Cross and Blue Shield of Florida Inc:企業の戦略的SWOT分析
    Blue Cross and Blue Shield of Florida Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Kuehne + Nagel International AG (KNIN):企業の財務・戦略的SWOT分析
    Kuehne + Nagel International AG (KNIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Lakes Oil NL (LKO):企業の財務・戦略的SWOT分析
    Summary Lakes Oil NL (Lake Oil) is an upstream company that carries out exploration and production oil and gas. The company acquires, explores, and develops oil and natural gas properties. It operates Gippsland basin and Otway basin in Australia. Lake Oil offers re-processing and re-mapping of avail …
  • Immune Design Corp (IMDZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Immune Design Corp (Immune Design) is a clinical-stage immunotherapy company that discovers and develops in vivo immunotherapy treatments to target cancer and other chronic diseases. The company develops its product candidates through its ZVex and GLAAS discovery platforms. Immune Design’s p …
  • 3M Company:戦略・SWOT・企業財務分析
    3M Company - Strategy, SWOT and Corporate Finance Report Summary 3M Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Compass Minerals International Inc (CMP):企業の財務・戦略的SWOT分析
    Compass Minerals International Inc (CMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆